HEADER TRANSFERASE/TRANSFERASE INHIBITOR 20-DEC-12 4IJ1 TITLE BIANTHRANILATE-LIKE ANALOGUE BOUND TO ANTHRANILATE TITLE 2 PHOSPHORIBOSYLTRANSFERASE (ANPRT; TRPD) IN ABSENCE OF SUBSTRATES. COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.4.2.18; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 STRAIN: H37RV; SOURCE 5 GENE: MT2248, MTCY190.03C, RV2192C, TRPD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) PGROESL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET23A KEYWDS INHIBITOR COMPLEX, BI-ANTHRANILATE ANALOGUE, TB STRUCTURAL GENOMICS KEYWDS 2 CONSORTIUM, TBSGC, PHOSPHORIBOSYLTRANSFERASE, TRANSFERASE- KEYWDS 3 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.L.EVANS,E.N.BAKER,J.S.LOTT,TB STRUCTURAL GENOMICS CONSORTIUM AUTHOR 2 (TBSGC) REVDAT 4 20-SEP-23 4IJ1 1 REMARK SEQADV REVDAT 3 15-NOV-17 4IJ1 1 REMARK REVDAT 2 21-MAY-14 4IJ1 1 JRNL REVDAT 1 25-DEC-13 4IJ1 0 JRNL AUTH G.L.EVANS,S.A.GAMAGE,E.M.BULLOCH,E.N.BAKER,W.A.DENNY, JRNL AUTH 2 J.S.LOTT JRNL TITL REPURPOSING THE CHEMICAL SCAFFOLD OF THE ANTI-ARTHRITIC DRUG JRNL TITL 2 LOBENZARIT TO TARGET TRYPTOPHAN BIOSYNTHESIS IN JRNL TITL 3 MYCOBACTERIUM TUBERCULOSIS. JRNL REF CHEMBIOCHEM V. 15 852 2014 JRNL REFN ISSN 1439-4227 JRNL PMID 24623674 JRNL DOI 10.1002/CBIC.201300628 REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.3_928) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 65362 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 3317 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.6175 - 4.4135 1.00 4232 230 0.1776 0.1993 REMARK 3 2 4.4135 - 3.5035 1.00 4160 228 0.1650 0.1877 REMARK 3 3 3.5035 - 3.0607 1.00 4127 236 0.1992 0.2670 REMARK 3 4 3.0607 - 2.7809 1.00 4128 229 0.2062 0.2426 REMARK 3 5 2.7809 - 2.5816 1.00 4142 233 0.2046 0.2690 REMARK 3 6 2.5816 - 2.4294 1.00 4101 240 0.1926 0.2413 REMARK 3 7 2.4294 - 2.3077 1.00 4172 196 0.1991 0.2426 REMARK 3 8 2.3077 - 2.2073 1.00 4125 207 0.2048 0.2598 REMARK 3 9 2.2073 - 2.1223 1.00 4154 197 0.1972 0.2418 REMARK 3 10 2.1223 - 2.0491 1.00 4106 210 0.2141 0.2729 REMARK 3 11 2.0491 - 1.9850 1.00 4101 239 0.2120 0.2734 REMARK 3 12 1.9850 - 1.9282 1.00 4155 224 0.2403 0.2648 REMARK 3 13 1.9282 - 1.8775 1.00 4123 204 0.2765 0.3464 REMARK 3 14 1.8775 - 1.8317 1.00 4131 230 0.3014 0.3230 REMARK 3 15 1.8317 - 1.7900 1.00 4088 214 0.3204 0.3738 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.30 REMARK 3 SHRINKAGE RADIUS : 1.11 REMARK 3 K_SOL : 0.34 REMARK 3 B_SOL : 29.52 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.240 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.380 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.09460 REMARK 3 B22 (A**2) : -5.49910 REMARK 3 B33 (A**2) : 2.48960 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -5.08980 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4967 REMARK 3 ANGLE : 1.126 6770 REMARK 3 CHIRALITY : 0.070 786 REMARK 3 PLANARITY : 0.005 894 REMARK 3 DIHEDRAL : 13.564 1692 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4IJ1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-JAN-13. REMARK 100 THE DEPOSITION ID IS D_1000076813. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8983 REMARK 200 MONOCHROMATOR : SILICON DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS (KABSCH REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65430 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.594 REMARK 200 RESOLUTION RANGE LOW (A) : 95.201 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.14500 REMARK 200 R SYM (I) : 0.17200 REMARK 200 FOR THE DATA SET : 6.7100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.59 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 3.34800 REMARK 200 R SYM FOR SHELL (I) : 4.09600 REMARK 200 FOR SHELL : 0.310 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3QR9 CHAIN A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M IMIDAZOLE.MALATE, 15% PEG4000, PH REMARK 280 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 47.39950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.02500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 47.39950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 39.02500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 VAL A 1 REMARK 465 ALA A 2 REMARK 465 LEU A 3 REMARK 465 SER A 4 REMARK 465 ALA A 5 REMARK 465 GLU A 6 REMARK 465 GLY A 7 REMARK 465 SER A 8 REMARK 465 SER A 9 REMARK 465 GLY A 10 REMARK 465 GLY A 11 REMARK 465 SER A 12 REMARK 465 ARG A 13 REMARK 465 GLY A 14 REMARK 465 GLY A 15 REMARK 465 SER A 16 REMARK 465 PRO A 17 REMARK 465 LYS A 18 REMARK 465 ALA A 19 REMARK 465 GLU A 20 REMARK 465 ALA A 21 REMARK 465 ALA A 22 REMARK 465 SER A 23 REMARK 465 VAL A 24 REMARK 465 ASP A 111 REMARK 465 GLY A 112 REMARK 465 VAL A 113 REMARK 465 ASN A 114 REMARK 465 ALA A 141 REMARK 465 SER A 142 REMARK 465 SER A 143 REMARK 465 LEU A 144 REMARK 465 SER A 145 REMARK 465 GLY A 146 REMARK 465 ARG A 333 REMARK 465 LEU A 371 REMARK 465 GLU A 372 REMARK 465 HIS A 373 REMARK 465 HIS A 374 REMARK 465 HIS A 375 REMARK 465 HIS A 376 REMARK 465 HIS A 377 REMARK 465 HIS A 378 REMARK 465 HIS A 379 REMARK 465 MET B 0 REMARK 465 VAL B 1 REMARK 465 ALA B 2 REMARK 465 LEU B 3 REMARK 465 SER B 4 REMARK 465 ALA B 5 REMARK 465 GLU B 6 REMARK 465 GLY B 7 REMARK 465 SER B 8 REMARK 465 SER B 9 REMARK 465 GLY B 10 REMARK 465 GLY B 11 REMARK 465 SER B 12 REMARK 465 ARG B 13 REMARK 465 GLY B 14 REMARK 465 GLY B 15 REMARK 465 SER B 16 REMARK 465 PRO B 17 REMARK 465 LYS B 18 REMARK 465 ALA B 19 REMARK 465 GLU B 20 REMARK 465 ALA B 21 REMARK 465 ALA B 22 REMARK 465 SER B 23 REMARK 465 VAL B 24 REMARK 465 GLY B 110 REMARK 465 ASP B 111 REMARK 465 GLY B 112 REMARK 465 VAL B 113 REMARK 465 ALA B 141 REMARK 465 SER B 142 REMARK 465 SER B 143 REMARK 465 LEU B 144 REMARK 465 SER B 145 REMARK 465 ALA B 334 REMARK 465 LEU B 371 REMARK 465 GLU B 372 REMARK 465 HIS B 373 REMARK 465 HIS B 374 REMARK 465 HIS B 375 REMARK 465 HIS B 376 REMARK 465 HIS B 377 REMARK 465 HIS B 378 REMARK 465 HIS B 379 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 100 CG OD1 OD2 REMARK 470 VAL A 116 CG1 CG2 REMARK 470 GLY A 147 N CA REMARK 470 ARG A 157 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 238 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 252 CG CD OE1 OE2 REMARK 470 ASP A 270 CG OD1 OD2 REMARK 470 GLN A 295 CG CD OE1 NE2 REMARK 470 SER A 332 OG REMARK 470 GLU A 335 CG CD OE1 OE2 REMARK 470 ARG A 368 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 369 CG CD OE1 NE2 REMARK 470 ARG B 58 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 100 CG OD1 OD2 REMARK 470 ASN B 114 CG OD1 ND2 REMARK 470 ARG B 157 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 225 CG OD1 OD2 REMARK 470 LEU B 250 CG CD1 CD2 REMARK 470 GLU B 252 CG CD OE1 OE2 REMARK 470 THR B 257 OG1 CG2 REMARK 470 GLN B 285 CG CD OE1 NE2 REMARK 470 LEU B 286 CG CD1 CD2 REMARK 470 ASP B 287 CG OD1 OD2 REMARK 470 ALA B 290 CB REMARK 470 SER B 332 OG REMARK 470 ARG B 333 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 335 CG CD OE1 OE2 REMARK 470 GLN B 369 CG CD OE1 NE2 REMARK 470 ILE B 370 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 56 39.20 -96.22 REMARK 500 ALA A 73 101.67 83.77 REMARK 500 ASP A 251 40.22 -96.76 REMARK 500 THR A 257 -166.50 -172.23 REMARK 500 GLN A 369 53.90 -104.70 REMARK 500 ALA B 73 101.54 86.66 REMARK 500 ASP B 247 4.52 -69.59 REMARK 500 ASP B 251 46.68 -91.31 REMARK 500 ASP B 287 -9.63 -58.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 17C A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 17C B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 404 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4GIU RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 4GKM RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: TB-RV2192C RELATED DB: TARGETTRACK DBREF 4IJ1 A 0 370 UNP P66992 TRPD_MYCTU 1 370 DBREF 4IJ1 B 0 370 UNP P66992 TRPD_MYCTU 1 370 SEQADV 4IJ1 VAL A 1 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 LEU A 371 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 GLU A 372 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS A 373 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS A 374 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS A 375 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS A 376 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS A 377 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS A 378 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS A 379 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 VAL B 1 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 LEU B 371 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 GLU B 372 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS B 373 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS B 374 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS B 375 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS B 376 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS B 377 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS B 378 UNP P66992 EXPRESSION TAG SEQADV 4IJ1 HIS B 379 UNP P66992 EXPRESSION TAG SEQRES 1 A 380 MET VAL ALA LEU SER ALA GLU GLY SER SER GLY GLY SER SEQRES 2 A 380 ARG GLY GLY SER PRO LYS ALA GLU ALA ALA SER VAL PRO SEQRES 3 A 380 SER TRP PRO GLN ILE LEU GLY ARG LEU THR ASP ASN ARG SEQRES 4 A 380 ASP LEU ALA ARG GLY GLN ALA ALA TRP ALA MET ASP GLN SEQRES 5 A 380 ILE MET THR GLY ASN ALA ARG PRO ALA GLN ILE ALA ALA SEQRES 6 A 380 PHE ALA VAL ALA MET THR MET LYS ALA PRO THR ALA ASP SEQRES 7 A 380 GLU VAL GLY GLU LEU ALA GLY VAL MET LEU SER HIS ALA SEQRES 8 A 380 HIS PRO LEU PRO ALA ASP THR VAL PRO ASP ASP ALA VAL SEQRES 9 A 380 ASP VAL VAL GLY THR GLY GLY ASP GLY VAL ASN THR VAL SEQRES 10 A 380 ASN LEU SER THR MET ALA ALA ILE VAL VAL ALA ALA ALA SEQRES 11 A 380 GLY VAL PRO VAL VAL LYS HIS GLY ASN ARG ALA ALA SER SEQRES 12 A 380 SER LEU SER GLY GLY ALA ASP THR LEU GLU ALA LEU GLY SEQRES 13 A 380 VAL ARG ILE ASP LEU GLY PRO ASP LEU VAL ALA ARG SER SEQRES 14 A 380 LEU ALA GLU VAL GLY ILE GLY PHE CYS PHE ALA PRO ARG SEQRES 15 A 380 PHE HIS PRO SER TYR ARG HIS ALA ALA ALA VAL ARG ARG SEQRES 16 A 380 GLU ILE GLY VAL PRO THR VAL PHE ASN LEU LEU GLY PRO SEQRES 17 A 380 LEU THR ASN PRO ALA ARG PRO ARG ALA GLY LEU ILE GLY SEQRES 18 A 380 CYS ALA PHE ALA ASP LEU ALA GLU VAL MET ALA GLY VAL SEQRES 19 A 380 PHE ALA ALA ARG ARG SER SER VAL LEU VAL VAL HIS GLY SEQRES 20 A 380 ASP ASP GLY LEU ASP GLU LEU THR THR THR THR THR SER SEQRES 21 A 380 THR ILE TRP ARG VAL ALA ALA GLY SER VAL ASP LYS LEU SEQRES 22 A 380 THR PHE ASP PRO ALA GLY PHE GLY PHE ALA ARG ALA GLN SEQRES 23 A 380 LEU ASP GLN LEU ALA GLY GLY ASP ALA GLN ALA ASN ALA SEQRES 24 A 380 ALA ALA VAL ARG ALA VAL LEU GLY GLY ALA ARG GLY PRO SEQRES 25 A 380 VAL ARG ASP ALA VAL VAL LEU ASN ALA ALA GLY ALA ILE SEQRES 26 A 380 VAL ALA HIS ALA GLY LEU SER SER ARG ALA GLU TRP LEU SEQRES 27 A 380 PRO ALA TRP GLU GLU GLY LEU ARG ARG ALA SER ALA ALA SEQRES 28 A 380 ILE ASP THR GLY ALA ALA GLU GLN LEU LEU ALA ARG TRP SEQRES 29 A 380 VAL ARG PHE GLY ARG GLN ILE LEU GLU HIS HIS HIS HIS SEQRES 30 A 380 HIS HIS HIS SEQRES 1 B 380 MET VAL ALA LEU SER ALA GLU GLY SER SER GLY GLY SER SEQRES 2 B 380 ARG GLY GLY SER PRO LYS ALA GLU ALA ALA SER VAL PRO SEQRES 3 B 380 SER TRP PRO GLN ILE LEU GLY ARG LEU THR ASP ASN ARG SEQRES 4 B 380 ASP LEU ALA ARG GLY GLN ALA ALA TRP ALA MET ASP GLN SEQRES 5 B 380 ILE MET THR GLY ASN ALA ARG PRO ALA GLN ILE ALA ALA SEQRES 6 B 380 PHE ALA VAL ALA MET THR MET LYS ALA PRO THR ALA ASP SEQRES 7 B 380 GLU VAL GLY GLU LEU ALA GLY VAL MET LEU SER HIS ALA SEQRES 8 B 380 HIS PRO LEU PRO ALA ASP THR VAL PRO ASP ASP ALA VAL SEQRES 9 B 380 ASP VAL VAL GLY THR GLY GLY ASP GLY VAL ASN THR VAL SEQRES 10 B 380 ASN LEU SER THR MET ALA ALA ILE VAL VAL ALA ALA ALA SEQRES 11 B 380 GLY VAL PRO VAL VAL LYS HIS GLY ASN ARG ALA ALA SER SEQRES 12 B 380 SER LEU SER GLY GLY ALA ASP THR LEU GLU ALA LEU GLY SEQRES 13 B 380 VAL ARG ILE ASP LEU GLY PRO ASP LEU VAL ALA ARG SER SEQRES 14 B 380 LEU ALA GLU VAL GLY ILE GLY PHE CYS PHE ALA PRO ARG SEQRES 15 B 380 PHE HIS PRO SER TYR ARG HIS ALA ALA ALA VAL ARG ARG SEQRES 16 B 380 GLU ILE GLY VAL PRO THR VAL PHE ASN LEU LEU GLY PRO SEQRES 17 B 380 LEU THR ASN PRO ALA ARG PRO ARG ALA GLY LEU ILE GLY SEQRES 18 B 380 CYS ALA PHE ALA ASP LEU ALA GLU VAL MET ALA GLY VAL SEQRES 19 B 380 PHE ALA ALA ARG ARG SER SER VAL LEU VAL VAL HIS GLY SEQRES 20 B 380 ASP ASP GLY LEU ASP GLU LEU THR THR THR THR THR SER SEQRES 21 B 380 THR ILE TRP ARG VAL ALA ALA GLY SER VAL ASP LYS LEU SEQRES 22 B 380 THR PHE ASP PRO ALA GLY PHE GLY PHE ALA ARG ALA GLN SEQRES 23 B 380 LEU ASP GLN LEU ALA GLY GLY ASP ALA GLN ALA ASN ALA SEQRES 24 B 380 ALA ALA VAL ARG ALA VAL LEU GLY GLY ALA ARG GLY PRO SEQRES 25 B 380 VAL ARG ASP ALA VAL VAL LEU ASN ALA ALA GLY ALA ILE SEQRES 26 B 380 VAL ALA HIS ALA GLY LEU SER SER ARG ALA GLU TRP LEU SEQRES 27 B 380 PRO ALA TRP GLU GLU GLY LEU ARG ARG ALA SER ALA ALA SEQRES 28 B 380 ILE ASP THR GLY ALA ALA GLU GLN LEU LEU ALA ARG TRP SEQRES 29 B 380 VAL ARG PHE GLY ARG GLN ILE LEU GLU HIS HIS HIS HIS SEQRES 30 B 380 HIS HIS HIS HET 17C A 401 19 HET GOL A 402 6 HET IMD A 403 5 HET IMD A 404 5 HET 17C B 401 19 HET GOL B 402 6 HET GOL B 403 6 HET GOL B 404 6 HETNAM 17C 2,2'-IMINODIBENZOIC ACID HETNAM GOL GLYCEROL HETNAM IMD IMIDAZOLE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 17C 2(C14 H11 N O4) FORMUL 4 GOL 4(C3 H8 O3) FORMUL 5 IMD 2(C3 H5 N2 1+) FORMUL 11 HOH *396(H2 O) HELIX 1 1 SER A 26 ASP A 36 1 11 HELIX 2 2 GLY A 43 THR A 54 1 12 HELIX 3 3 ARG A 58 ALA A 73 1 16 HELIX 4 4 THR A 75 ALA A 90 1 16 HELIX 5 5 VAL A 116 ALA A 129 1 14 HELIX 6 6 ALA A 148 LEU A 154 1 7 HELIX 7 7 GLY A 161 VAL A 172 1 12 HELIX 8 8 ALA A 179 HIS A 183 1 5 HELIX 9 9 TYR A 186 GLY A 197 1 12 HELIX 10 10 THR A 200 ASN A 203 5 4 HELIX 11 11 LEU A 204 THR A 209 1 6 HELIX 12 12 PHE A 223 ARG A 237 1 15 HELIX 13 13 ASP A 275 GLY A 280 5 6 HELIX 14 14 GLN A 285 ALA A 290 5 6 HELIX 15 15 ASP A 293 GLY A 306 1 14 HELIX 16 16 GLY A 310 GLY A 329 1 20 HELIX 17 17 GLU A 335 THR A 353 1 19 HELIX 18 18 GLY A 354 GLN A 369 1 16 HELIX 19 19 SER B 26 ASP B 36 1 11 HELIX 20 20 GLY B 43 THR B 54 1 12 HELIX 21 21 ARG B 58 LYS B 72 1 15 HELIX 22 22 THR B 75 ALA B 90 1 16 HELIX 23 23 THR B 115 ALA B 129 1 15 HELIX 24 24 GLY B 147 LEU B 154 1 8 HELIX 25 25 GLY B 161 GLY B 173 1 13 HELIX 26 26 ALA B 179 HIS B 183 1 5 HELIX 27 27 TYR B 186 GLY B 197 1 12 HELIX 28 28 THR B 200 THR B 209 5 10 HELIX 29 29 PHE B 223 ARG B 237 1 15 HELIX 30 30 ASP B 275 GLY B 280 5 6 HELIX 31 31 GLN B 285 LEU B 289 5 5 HELIX 32 32 ASP B 293 GLY B 306 1 14 HELIX 33 33 GLY B 310 GLY B 329 1 20 HELIX 34 34 LEU B 330 SER B 332 5 3 HELIX 35 35 TRP B 336 THR B 353 1 18 HELIX 36 36 GLY B 354 ILE B 370 1 17 SHEET 1 A 5 VAL A 103 GLY A 107 0 SHEET 2 A 5 ALA A 216 GLY A 220 1 O GLY A 220 N VAL A 106 SHEET 3 A 5 SER A 240 GLY A 246 1 O LEU A 242 N ILE A 219 SHEET 4 A 5 SER A 259 ALA A 265 -1 O THR A 260 N HIS A 245 SHEET 5 A 5 SER A 268 PHE A 274 -1 O PHE A 274 N SER A 259 SHEET 1 B 2 VAL A 133 GLY A 137 0 SHEET 2 B 2 ILE A 174 PHE A 178 1 O CYS A 177 N LYS A 135 SHEET 1 C 5 VAL B 103 GLY B 107 0 SHEET 2 C 5 ALA B 216 GLY B 220 1 O GLY B 220 N VAL B 106 SHEET 3 C 5 SER B 240 GLY B 246 1 O VAL B 244 N ILE B 219 SHEET 4 C 5 SER B 259 VAL B 264 -1 O VAL B 264 N VAL B 241 SHEET 5 C 5 LYS B 271 PHE B 274 -1 O LEU B 272 N ILE B 261 SHEET 1 D 2 VAL B 133 GLY B 137 0 SHEET 2 D 2 ILE B 174 PHE B 178 1 O GLY B 175 N LYS B 135 SITE 1 AC1 13 MET A 86 ASN A 138 ALA A 179 PRO A 180 SITE 2 AC1 13 HIS A 183 TYR A 186 ARG A 187 ALA A 190 SITE 3 AC1 13 ARG A 193 ARG A 194 GOL A 402 HOH A 533 SITE 4 AC1 13 HOH A 696 SITE 1 AC2 5 GLY A 107 GLY A 206 PRO A 207 17C A 401 SITE 2 AC2 5 HOH A 697 SITE 1 AC3 6 ARG A 237 LEU A 305 GLY A 306 GLY A 307 SITE 2 AC3 6 ILE A 351 GLU A 357 SITE 1 AC4 4 TRP A 47 ASP A 50 GLU A 342 ARG A 346 SITE 1 AC5 12 HIS B 91 ASN B 138 PRO B 180 ARG B 181 SITE 2 AC5 12 HIS B 183 TYR B 186 ARG B 187 ALA B 190 SITE 3 AC5 12 ARG B 194 GOL B 403 HOH B 536 HOH B 679 SITE 1 AC6 6 ALA B 46 TRP B 47 ASP B 50 GLU B 342 SITE 2 AC6 6 ARG B 346 HOH B 539 SITE 1 AC7 5 HIS B 91 PRO B 162 ARG B 181 ARG B 194 SITE 2 AC7 5 17C B 401 SITE 1 AC8 11 ALA B 236 ARG B 237 ARG B 238 LEU B 305 SITE 2 AC8 11 GLY B 306 GLY B 307 ILE B 351 ASP B 352 SITE 3 AC8 11 GLU B 357 HOH B 592 HOH B 663 CRYST1 94.799 78.050 101.973 90.00 111.00 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010549 0.000000 0.004049 0.00000 SCALE2 0.000000 0.012812 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010504 0.00000